Tower Hamlets NHS Talking Therapies

Award

Value

£8,494,500

Classifications

  • Health services

Tags

  • award
  • contract

Published

2 years ago

Description

NHS NEL has a requirement to ensure the continued provision of NHS Talking Therapies (NTT) across all its borough based areas that meet the Long Term Plan (LTP) five-year plan to 23/24 requirements: 
-	Increase access to NTT services as outlined in the LTP trajectories
-	Offer NTT-Long Term Conditions (NTT-LTC) services (including
co-location of therapists in primary care)
-	Meet NTT referral to treatment time and recovery standards: 50% NTT recovery rate; 75% of people accessing treatment within 6 weeks NTT waiting time; and 95% of people accessing treatment within 18 weeks NTT waiting time
-	First to Second appointment waits (assessment to treatment) 90% under 90 days. 
The existing Tower Hamlets Primary Care Psychological Therapies contract, known locally as Tower Hamlets Talking Therapies, with East London NHS Foundation Trust (ELFT) will end on 30 September 2023 and it is NHS NEL's intention to re-award the contract to the incumbent provider for 12 months with an option to extend for 6 months. 
Annual contract value: £5,663,000

Similar Contracts

Open

Provision of Hypertension and Lipids Management Services

NHS Norfolk and Waveney Integrated Care Board is seeking a procure a Hypertension and Lipids Optimisation service. The successful provider staff will be expected to work with the ICB Cardiovascular disease team, the N&W Protect NoW team, and General Practice to improve clinical effectiveness through case finding and management of patients.<br/><br/>NHS Norfolk and Waveney Integrated Care Board is seeking to launch a large-scale CVD Prevention project using a Population Health Management approach to case finding and intervention. The project will focus on hypertension and lipid management, with patients being identified and subsequently risk-stratified using the ICB software.<br/><br/>The ABCDE program aims to improve the care of patients at risk of Cardiovascular events through case finding and improved management of high-risk individuals. This project is considered a system priority to see our population lead healthier, longer lives, whilst simultaneously reducing pressures on the health system through early detection and management.<br/><br/>The successful provider is expected to supply and manage Clinical Prescribers who will liaise with the ICB Protect NoW team, General Practice, and patients. A personalised care approach will be used to support pharmacological and social prescribing for our patient cohort.<br/>Prescribers must be able to initiate relevant medicines.<br/>Prescribers must initiate medicines in line with N&W criteria.<br/><br/>Patients will be identified using the ICB’s population health management software (Eclipse). The ICB Protect NoW Team will contact patients via digital (and print, if necessary) mediums to inform them of their relative risks and changes they can make in their lifestyles and diets and to encourage medication adherence where necessary.<br/><br/>Patients identified as eligible for medication will be consented by Protect NoW and subsequently made available to the provider, and the prescribers are to systematically contact this patient cohort and seek to initiate and / or optimise treatment in line with ICB and national guidance.<br/><br/>The provider will be expected to liaise with the relevant Practice where required on necessary ongoing management and monitoring.

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Timeline complete

Publish
Bid
Evaluate
Award
Complete